Miguel Antelo, MD
Urology · Nashua, NHNPI 1720069545
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,650 of the $4,286 with a category attached, or 61.8%. Gyrus ACMI, Inc. accounts for 61.8% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $2,710, more than ten times the $39 reported in 2019.
Across 26 payments — averaging $164.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gyrus ACMI, Inc.$3K
- Boston Scientific$1K
- Dentsply IH AB$200
- AbbVie$55
- Laborie Medical Technologies Corp.$30
- Teleflex LLC$29
- plus $95 from 4 others
What the payments were for
- Consulting fees$2,65062%
- Travel & lodging$1,05925%
- Food & beverage$57713%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gyrus ACMI, Inc. | 2 | $2,650 |
| Boston Scientific | 8 | $1,227 |
| Dentsply IH AB | 8 | $200 |
| AbbVie | 2 | $55 |
| Laborie Medical Technologies Corp. | 1 | $30 |
| Teleflex LLC | 1 | $29 |
| Tempus AI, Inc | 1 | $25 |
| Rochester Medical Corporation | 1 | $24 |
| Medtronic | 1 | $24 |
| Astellas Pharma US Inc | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Soltive$2,650
- Moses 550 D\F\L$1,059
How this compares
$4,286 in reported general payments places this provider in the 80th percentile of 61 urology providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 116 | $78,063 |
| GemtesaVibegron | 31 | $26,169 |
| Mirabegron ErMirabegron | 28 | $15,264 |
| Tamsulosin Hcl | 479 | $9,111 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 164 | $3,789 |
| Finasteride | 193 | $3,520 |
| Oxybutynin Chloride ErOxybutynin Chloride | 146 | $3,245 |
| Solifenacin Succinate | 43 | $2,653 |
| Trospium Chloride | 38 | $2,383 |
| Silodosin | 27 | $1,503 |
| Estradiol | 18 | $1,143 |
| Potassium Citrate ErPotassium Citrate | 13 | $1,136 |
| Bethanechol Chloride | 11 | $859 |
| Cefpodoxime Proxetil | 15 | $633 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 11 | $505 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $23 | $78,063116 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 61 urology providers in New Hampshire.
Other urology in Nashua
- Matthew JohnsonNashua$6K
- Vassili GlazyrineNashua$3K
- Stephen HillNashua$1K
- Gary DunetzNashua$666
- Matthew StanizziNashua$79
- Martin GrossKeene$172K
- Ramiro Madden-FuentesConcord$82K
- Jason AkermanManchester$53K
- Lori LernerLebanon$49K
- E William JohnsonExeter$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.